You are here

Lobe Sciences Ltd.

Lobe Sciences Ltd.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
LOBE
CSE Index: 
Currency: 

Lobe Sciences is a biopharmaceutical company focused on developing medicines to treat diseases with unmet medical needs. The Company, through collaboration with industry-leading partners, is engaged in novel research and development focused on treating chronic cluster headache (an orphan disease), refractive anxiety, and sickle cell disease. The Company is engaged in Phase 1 and Phase 2 activities in its drug portfolio, and intends to initiate the launch of Altemia®, a medical food designed to meet the needs of sickle cell patients globally.

You are here

Lobe Sciences Ltd. (LOBE)

SEDAR Information

Company Info

Address
1771 Robson Street #1614
Vancouver, BC V6G 3B7
Canada
Phone
1-949-505-5623
Email
[email protected]
Website
http://www.lobesciences.com
Listing date
Friday, June 7, 2019

Capitalization

Issued & Outstanding: 
171560392
Reserved for Issuance: 
39369671

Company Officers

Mathew Lee, CFO
Dr. Fred D. Sancilio, Chairman and CEO
Rick Goulburn, President

News Releases

16/08/2024

News release

12/08/2024

News release

Bulletins

09/06/2022

2022-0613 – Consolidation - Lobe Sciences Ltd. (LOBE)

le 9 juin/June 2022

Lobe Sciences Ltd. (the "Issuer") has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every six (6) pre-consolidated common shares.

As a result, the outstanding common shares of the Issuer will be reduced to approximately 38,230,000 common shares.

CSE Filings